TIME TO REBOUND IN JOINT SYMPTOMS FOLLOWING DISCONTINUATION OF TNFI THERAPY AFTER ACHIEVING LOW DISEASE ACTIVITY OR REMISSION IN PSORIATIC ARTHRITIS PATIENTS ENROLLED IN THE US CORRONA REGISTRY

被引：0
|
作者：
Harrold, L. R. [1 ]
Stolshek, B. [2 ]
Rebello, S. [1 ]
Collier, D. [2 ]
Mutebi, A. [2 ]
Wade, S. W. [3 ]
Malley, W. [1 ]
Greenberg, J. D. [1 ]
Etzel, C. J. [1 ]
机构：
[1] Corrona LLC, Southborough, MA USA
[2] Amgen Inc, Thousand Oaks, CA 91320 USA
[3] Wade Outcomes Res Consulting, Salt Lake City, UT USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.1324
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0423
引用
收藏
页码：342 / 343
页数：2
相关论文
共 34 条
  • [11] Maintenance of Sustained Low Disease Activity or Remission in Patients With Rheumatoid Arthritis Treated With Etanercept Monotherapy: Results from the Corrona Registry
    Pappas, Dimitrios A.
    Shan, Ying
    Lesperance, Tamara
    Kricorian, Greg
    Karis, Elaine
    Rebello, Sabrina
    Hua, Winnie
    Accortt, Neil A.
    Stryker, Scott
    ACR OPEN RHEUMATOLOGY, 2020, 2 (10) : 588 - 594
  • [12] BIOLOGIC THERAPY, TIME TO LOW DISEASE ACTIVITY, AND EFFECT OF MONO VS. BACKGROUND ORAL DMARD THERAPY AMONG PSORIATIC ARTHRITIS PATIENTS IN A US REGISTRY
    Mease, P.
    Collier, D.
    Saunders, K.
    Grant, S.
    Bitman, B.
    Chaudhari, M.
    Greenberg, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 671 - 671
  • [13] Discontinuation of tofacitinib after achieving low disease activity in patients with rheumatoid arthritis: a multicentre, observational study
    Kubo, Satoshi
    Yamaoka, Kunihiro
    Amano, Koichi
    Nagano, Shuji
    Tohma, Shigeto
    Suematsu, Eiichi
    Nagasawa, Hayato
    Iwata, Kanako
    Tanaka, Yoshiya
    RHEUMATOLOGY, 2017, 56 (08) : 1293 - 1301
  • [14] Achieving comprehensive remission or low disease activity in rheumatoid patients and its impact on workability - Saudi Rheumatoid Arthritis Registry
    Almoallim, Hani
    Janoudi, Nahid
    Alokaily, Fandah
    Alzahrani, Zeyad
    Algohary, Shereen
    Alosaimi, Hanan
    Attar, Suzan
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2019, 11 : 89 - 95
  • [15] PSORIATIC ARTHRITIS PATIENTS ACHIEVING DAPSA REMISSION/LOW DISEASE ACTIVITY HAVE BETTER LONG-TERM FUNCTIONAL OUTCOMES
    Vargas Cruz, L.
    Boechat Farani, J.
    Rabello Costa, J.
    Menegat, F.
    Andrade Aguas, J. V.
    Ruschel, B.
    Gasparin, A. A.
    Brenol, C.
    Kohem, C.
    Palominos, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1723 - 1724
  • [16] Discontinuation of tumour necrosis factor inhibitors in patients with rheumatoid arthritis in low-disease activity: persistent benefits. Data from the Corrona registry
    Kavanaugh, Arthur
    Lee, Susan J.
    Curtis, Jeffrey R.
    Greenberg, Jeffrey D.
    Kremer, Joel M.
    Soto, Lilian
    Etzel, Carol J.
    Cox, Vanessa
    Yoshida, Kazuki
    Reed, George W.
    Solomon, Daniel H.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (06) : 1150 - 1155
  • [17] What Are the Benefits of Treating Rheumatoid Arthritis Patients to Remission After Achieving Low Disease Activity in Clinical Practice?
    Zhao, Jing
    Sbarigia, Urbano
    Kwong, Jackie
    Naik, Chinmayi
    Zazzetti, Federico
    Shadick, Nancy
    Weinblatt, Michael
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3559 - 3561
  • [18] Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study
    Tanaka, Y.
    Takeuchi, T.
    Mimori, T.
    Saito, K.
    Nawata, M.
    Kameda, H.
    Nojima, T.
    Miyasaka, N.
    Koike, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (07) : 1286 - 1291
  • [19] DISCONTINUATION OF BARICITINIB AFTER ACHIEVING LOW DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CLINICAL PRACTICE; A MULTICENTER OBSERVATIONAL STUDY.
    Torikai, E.
    Hirano, Y.
    Suzuki, D.
    Kanayama, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 647 - 647
  • [20] Differences Between Early and Established Rheumatoid Arthritis in Time to Achieving CDAI but Not Fatigue Low Disease Activity and Remission: Data from the OBRI Registry
    Pope, Janet
    Rampakakis, Emmanouil
    Movahedi, Mohammad
    Cesta, Angela
    Sampalis, John
    Bombardier, Claire
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1070 - 1070
1234